Back

Montara names Dirk Landgraf chief business officer ahead of 2027 clinical trials

Verifying
  • Montara appointed founding investor Dirk Landgraf chief business officer and named Miles Gerson to its board.
  • Early 2027 is the planned timing for MTX-E1’s first-in-human studies.
  • Montara completed GLP safety studies of its first BrainOnly peripheral blocker.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.